Jack Michelle M, Greer Ristan M, Thomsett Michael J, Walker Rosslyn M, Bell John R, Choong Catherine, Cowley David M, Herington Adrian C, Cotterill Andrew M
Department of Paediatric Endocrinology, Mater Children's Hospital, South Brisbane, Australia.
Clin Endocrinol (Oxf). 2003 Mar;58(3):355-64. doi: 10.1046/j.1365-2265.2003.01725.x.
Hyperinsulinism of infancy (HI) is characterized by unregulated insulin secretion in the presence of hypoglycaemia, often resulting in brain damage. Pancreatic resection for control of hypoglycaemia is frequently resisted because of the risk of diabetes mellitus (DM). We investigated retrospectively 62 children with HI from nine Australian treatment centres born between 1972 and 1998, comparing endocrine and neurological outcome in 28 patients receiving medical therapy alone with 34 who required pancreatic resection to control their hypoglycaemia.
History, treatment and clinical course were ascertained from file audit and interview. Risk of DM (hazard ratio) attributable to age at surgery (< vs. > or = 100 days at last pancreatectomy) and extent of resection (< vs. > or = 95%) were calculated using Cox proportional hazards regression and categorical variables compared by the chi2-test. Neurological outcome (normal, mild deficit or severe deficit) was derived from the most authoritative source.
Surgically treated patients had a greater birthweight, earlier presentation and higher plasma insulin levels. Of 18 infants < 100 days and 16 > or = 100 days of age at surgery, four (all > or = 100 days) became diabetic as an immediate consequence of surgery and five (two < 100 days and three > or = 100 days) became diabetic 7-18 years later. Surgery > or = 100 days and pancreatectomy > or = 95% were associated with development of diabetes (HR = 12.61, CI 1.53-104.07 and HR = 7.03, CI 1.43-34.58, respectively). Neurodevelopmental outcome was no different between the surgical and medical groups with 44% overall with neurological deficits. Patients euglycaemic within 35 days of the first symptom of hypoglycaemia (Group A) had a better neurodevelopmental outcome than those still hypoglycaemic > 35 days from first presentation (Group B) (P = 0.007). Prolonged hypoglycaemia in Group B was due either to delayed diagnosis or to need for repeat surgery because of continued hypoglycaemia. Within Group A, medically treated patients (who presented later with apparently milder disease) had a higher incidence of neurodevelopmental deficit (n = 15, four mild, three severe deficit) compared with surgically treated patients (n = 18, two mild, none severe deficit) (P < 0.025).
Poor neurodevelopmental outcome remains a major problem in hyperinsulinism of infancy. Risk of diabetes mellitus with pancreatectomy varies according to age at surgery and extent of resection. Patients presenting early with severe disease have a better neurodevelopmental outcome and lower risk of diabetes if they are treated with early extensive surgery.
婴儿高胰岛素血症(HI)的特征是在低血糖情况下胰岛素分泌不受调节,常导致脑损伤。由于存在糖尿病(DM)风险,通过胰腺切除术控制低血糖常常遭到抵制。我们对来自澳大利亚九个治疗中心的62例1972年至1998年出生的HI患儿进行了回顾性研究,比较了28例仅接受药物治疗的患者与34例需要胰腺切除术来控制低血糖的患者的内分泌和神经学转归。
通过查阅病历和访谈确定病史、治疗及临床病程。使用Cox比例风险回归计算手术时年龄(最后一次胰腺切除时<100天与>或 = 100天)和切除范围(<95%与>或 = 95%)导致DM的风险(风险比),并通过卡方检验比较分类变量。神经学转归(正常、轻度缺陷或重度缺陷)来自最权威的资料来源。
接受手术治疗的患者出生体重更大、发病更早且血浆胰岛素水平更高。在手术时年龄<100天的18例婴儿和年龄>或 = 100天的16例婴儿中,4例(均>或 = 100天)术后立即患糖尿病,5例(2例<100天和3例>或 = 100天)在7 - 18年后患糖尿病。手术时年龄>或 = 100天以及胰腺切除范围>或 = 95%与糖尿病的发生相关(风险比分别为12.61,可信区间1.53 - 104.07和7.03,可信区间1.43 - 34.58)。手术组和药物治疗组的神经发育转归无差异,总体有44%存在神经缺陷。在出现低血糖首个症状后35天内血糖正常的患者(A组)比首次出现症状>35天后仍低血糖的患者(B组)神经发育转归更好(P = 0.007)。B组低血糖持续时间长是由于诊断延迟或因持续低血糖需要再次手术。在A组中,接受药物治疗的患者(发病较晚且病情明显较轻)与接受手术治疗的患者(发病较早且病情明显较重)相比,神经发育缺陷发生率更高(n = 15,4例轻度,3例重度缺陷)(n = 18,2例轻度,无重度缺陷)(P < 0.025)。
神经发育不良转归仍是婴儿高胰岛素血症的一个主要问题。胰腺切除术后患糖尿病的风险因手术时年龄和切除范围而异。早期出现严重疾病的患者如果接受早期广泛手术治疗,神经发育转归更好且患糖尿病风险更低。